Women with a higher-than-usual risk for developing breast cancer should consider taking one of two medications approved by the Food and Drug Administration to reduce that risk, a federal panel has concluded. But the medications, which can raise a woman's risk of developing blood clots, are not for everyone and should not be taken for breast cancer reduction by most women, the U.S. Preventive Services Task Force said.
Since 2015
Financial Expert Witness Testimony
San Diego, California
with liberty and justice for all
Providing legal and research professionals with expert witness aid and services for damage calculations, asset valuation, and economic analysis
